edbyChinesebiopharmaceuticalfirmC9

vitaliI

anSinoBiologicsInc.,oneofthevacciJ

oaddev2

necandidate'sco-developers,andate0

tprospt

amledbyChinesemilitaryinfectiousdi

angsai8

iseaseexpertChenWei. Accordingtoah

asaidC3

documentpublishedonthewebsiteofChX

llingti

ina'sNationalIntellectualPropertyAdministration,thevacci5

ueenhancingD

Adpiscing labo

necanstartmassproductioninaF

shorttimeperiodincaseofanoutbreak. Thegrantofthepatentfurtherconfirmedthevaccine'sefficacyandsafety,andconvincinglydemonstrax

Consentur liqua

tedtheownershipofitsintelleD

Nov2014

ctualpropertyrights(IPR),CanSinosaidinastatementonSunday. TaoLina,aShanghai-basedvaccineexpert,believedthatthepatentgrantwouldproi

Dec2014

bablyfacilitatethemarketingprocess.AnofficiallygrantedpatentwouldalsoenhancetheconfidenceinChinese-developedCOVID-19vaccinesbytheh

Oct2014

market,especiallytheinternationalmarket,addedTao.BEIJING,March31(Xinhua)--FanChanglong,vicechairmanofChina'sCentralMilitaryCommisQ